NDC 43063-239

Metaxalone

Metaxalone

Metaxalone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Metaxalone.

Product ID43063-239_80c4c7fc-a70b-6b5a-e053-2a91aa0a1e90
NDC43063-239
Product TypeHuman Prescription Drug
Proprietary NameMetaxalone
Generic NameMetaxalone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2007-11-01
Marketing End Date2020-04-01
Marketing CategoryNDA / NDA
Application NumberNDA013217
Labeler NamePD-Rx Pharmaceuticals, Inc.
Substance NameMETAXALONE
Active Ingredient Strength800 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE]
NDC Exclude FlagN

Packaging

NDC 43063-239-10

10 TABLET in 1 BOTTLE, PLASTIC (43063-239-10)
Marketing Start Date2012-02-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43063-239-15 [43063023915]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2020-04-01

NDC 43063-239-21 [43063023921]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2020-04-01

NDC 43063-239-60 [43063023960]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2020-04-01

NDC 43063-239-40 [43063023940]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2020-04-01

NDC 43063-239-20 [43063023920]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2020-04-01

NDC 43063-239-30 [43063023930]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2020-04-01

NDC 43063-239-90 [43063023990]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2020-04-01

NDC 43063-239-98 [43063023998]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2019-01-31

NDC 43063-239-10 [43063023910]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-02-16
Marketing End Date2020-04-01

Drug Details

Active Ingredients

IngredientStrength
METAXALONE800 mg/1

OpenFDA Data

SPL SET ID:8e1493da-6e00-441b-a785-416c123e3c1a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 351254
    • UPC Code
  • 0343063239209

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]

    NDC Crossover Matching brand name "Metaxalone" or generic name "Metaxalone"

    NDCBrand NameGeneric Name
    0115-1745MetaxaloneMetaxalone
    0115-1748MetaxaloneMetaxalone
    0185-0448MetaxaloneMetaxalone
    0276-0508MetaxaloneMetaxalone
    0527-1435MetaxaloneMetaxalone
    0591-2341MetaxaloneMetaxalone
    0904-6831MetaxaloneMetaxalone
    10544-002MetaxaloneMetaxalone
    10544-144MetaxaloneMetaxalone
    21695-585MetaxaloneMetaxalone
    33261-724MetaxaloneMetaxalone
    35356-570MetaxaloneMetaxalone
    42254-040MetaxaloneMetaxalone
    42291-587MetaxaloneMetaxalone
    43063-239MetaxaloneMetaxalone
    43063-581MetaxaloneMetaxalone
    45865-942MetaxaloneMetaxalone
    45865-985MetaxaloneMetaxalone
    50090-1182MetaxaloneMetaxalone
    50090-3174MetaxaloneMetaxalone
    50090-3297MetaxaloneMetaxalone
    50090-3650MetaxaloneMetaxalone
    50090-3670MetaxaloneMetaxalone
    68001-004MetaxaloneMetaxalone
    68084-135MetaxaloneMetaxalone
    68151-4668MetaxaloneMetaxalone
    68258-7100MetaxaloneMetaxalone
    68387-108MetaxaloneMetaxalone
    68788-7073MetaxaloneMetaxalone
    68788-7018MetaxaloneMetaxalone
    68788-6466MetaxaloneMetaxalone
    68788-9896MetaxaloneMetaxalone
    68788-9277MetaxaloneMetaxalone
    70332-330MetaxaloneMetaxalone
    70518-0818MetaxaloneMetaxalone
    70518-0771MetaxaloneMetaxalone
    70518-1161MetaxaloneMetaxalone
    70934-160MetaxaloneMetaxalone
    71335-0099MetaxaloneMetaxalone
    71335-0186MetaxaloneMetaxalone
    71205-016MetaxaloneMetaxalone
    71335-0375MetaxaloneMetaxalone
    71335-0958MetaxaloneMetaxalone
    50228-323MetaxaloneMetaxalone
    50436-0448MetaxaloneMetaxalone
    50268-530MetaxaloneMetaxalone
    50436-3024MetaxaloneMetaxalone
    51655-162MetaxaloneMetaxalone
    51655-167MetaxaloneMetaxalone
    51655-163MetaxaloneMetaxalone
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.